- Report
- March 2022
- 212 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Book
- April 2022
- 240 Pages
- Book
- January 2020
- 816 Pages
- Book
- April 2025
North America
- Book
- November 2024
North America
- Book
- September 2024
North America
- Book
- July 2024
North America
- Book
- May 2024
North America
- Book
- November 2023
North America
- Book
- October 2023
North America
- Book
- June 2023
North America
- Book
- November 2022
North America
- Book
- September 2022
North America
- Book
- April 2022
North America
- Book
- November 2021
North America
- Book
- July 2021
North America
- Book
- June 2021
North America
- Book
- November 2020
North America
- Book
- October 2020
North America

Otorhinolaryngology is a branch of medicine that focuses on the diagnosis and treatment of diseases and disorders of the ear, nose, and throat. It is an important field in drug discovery, as many of the drugs used to treat these conditions are developed through research and clinical trials. Otorhinolaryngology is a rapidly evolving field, with new treatments and therapies being developed to address a wide range of conditions.
Drug discovery in otorhinolaryngology is a complex process that involves the identification of new compounds, the development of new drugs, and the testing of these drugs in clinical trials. The process is often lengthy and expensive, but the potential rewards are great. New drugs can provide relief to patients suffering from a variety of conditions, and can also lead to improved quality of life.
Some of the major companies in the otorhinolaryngology market include GlaxoSmithKline, Merck, Pfizer, Novartis, and Sanofi. These companies are involved in the development of new drugs and treatments for a variety of conditions, including allergies, hearing loss, and sinusitis. They are also involved in the research and development of new technologies and treatments for otorhinolaryngology. Show Less Read more